10.00
Senseonics Holdings Inc stock is traded at $10.00, with a volume of 569.08K.
It is down -3.29% in the last 24 hours and up +5.04% over the past month.
Senseonics Holdings, Inc., a medical technology company, designs, develops, and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems that is designed to continually and accurately measure glucose levels in people with diabetes for a period of up to 90 and 180 days. The company has a research and development license agreement with TypeZero Technologies, Inc. and Roche Diabetes Care, Inc. to develop a closed loop diabetes management system that allow users to automatically maintain tight glucose control while avoiding hypoglycemia. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
See More
Previous Close:
$10.34
Open:
$10.28
24h Volume:
569.08K
Relative Volume:
0.75
Market Cap:
$528.74M
Revenue:
$40.71M
Net Income/Loss:
$-87.19M
P/E Ratio:
-4.997
EPS:
-2.0012
Net Cash Flow:
$-76.28M
1W Performance:
+4.38%
1M Performance:
+5.04%
6M Performance:
+47.93%
1Y Performance:
+8.70%
Senseonics Holdings Inc Stock (SENS) Company Profile
Name
Senseonics Holdings Inc
Sector
Industry
Phone
301-515-7260
Address
20451 Seneca Meadows Parkway, Germantown, MD
Compare SENS vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SENS
Senseonics Holdings Inc
|
10.00 | 528.74M | 40.71M | -87.19M | -76.28M | -2.0012 |
|
ABT
Abbott Laboratories
|
101.29 | 175.27B | 46.59B | 5.41B | 7.38B | 3.0938 |
|
MDT
Medtronic Plc
|
88.64 | 113.38B | 36.36B | 4.84B | 5.43B | 3.7261 |
|
SYK
Stryker Corp
|
272.36 | 104.47B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
BSX
Boston Scientific Corp
|
43.92 | 63.65B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
86.29 | 49.74B | 6.30B | 1.07B | 1.09B | 1.8406 |
Senseonics Holdings Inc Stock (SENS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Resumed | Stifel | Hold |
| Aug-27-25 | Initiated | Barclays | Overweight |
| Jul-15-25 | Initiated | TD Cowen | Buy |
| Jun-02-25 | Resumed | H.C. Wainwright | Buy |
| Apr-10-25 | Initiated | Mizuho | Outperform |
| Jul-19-23 | Initiated | Jefferies | Underperform |
| Aug-19-21 | Initiated | H.C. Wainwright | Buy |
| Apr-01-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Mar-05-21 | Downgrade | Raymond James | Mkt Perform → Underperform |
| Jan-21-21 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-20-21 | Downgrade | Craig Hallum | Hold → Sell |
| Aug-11-20 | Upgrade | BTIG Research | Neutral → Buy |
| Aug-11-20 | Upgrade | Craig Hallum | Sell → Hold |
| Mar-13-20 | Downgrade | BTIG Research | Buy → Neutral |
| Mar-13-20 | Downgrade | Guggenheim | Buy → Neutral |
| Nov-13-19 | Downgrade | Canaccord Genuity | Buy → Hold |
| Nov-13-19 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-23-19 | Initiated | Stifel | Buy |
| Jul-05-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jan-29-19 | Initiated | Piper Jaffray | Neutral |
| Aug-24-18 | Initiated | Dougherty & Company | Buy |
View All
Senseonics Holdings Inc Stock (SENS) Latest News
A Look at Senseonics Holdings Inc (SENS) After 3.3% Decline -- G - GuruFocus
Senseonics Holdings Inc (SENS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Senseonics Holdings, Inc. (SENS) Options ChainYahoo Finance - Yahoo! Finance Canada
Why is Senseonics (NYSE:SENS) in focus amid today’s penny stocks discussion? - Kalkine Media
Senseonics stock gains 2.86 percent as quarterly loss widens - ad-hoc-news.de
Sector Update: Healthcare Stocks Rise Late Afternoon - marketscreener.com
Beta Bionics, Senseonics to Integrate Diabetes Devices; Shares Rise - marketscreener.com
Update: Beta Bionics, Senseonics to Integrate Diabetes Devices; Shares Rise - Yahoo Finance
Beta Bionics partners with Senseonics on glucose monitoring By Investing.com - Investing.com Canada
Beta Bionics, Senseonics Partner to Integrate Diabetes Devices - Yahoo Finance
Beta Bionics partners with Senseonics on glucose monitoring - Investing.com
Beta Bionics Announces Partnership to Integrate iLet and mint AID Systems with Senseonics’ Eversense 365 CGM - Quiver Quantitative
A year-long glucose monitor is expected to join an automated insulin system in Q4 - Stock Titan
TD Cowen reiterates Senseonics stock rating on growth drivers By Investing.com - Investing.com Nigeria
Senseonics Holdings Inc. Share PriceSENS, RNS News, Articles, Quotes, & Charts (NASDAQ:SENS) - Proactive financial news
TD Cowen reiterates Senseonics stock rating on growth drivers - Investing.com
Senseonics Holdings, Inc.(NasdaqGS:SENS) added to S&P Healthcare Equipment Select Industry Index - marketscreener.com
Senseonics Holdings stock steadies after 1-for-20 reverse split and recent volatility - ad-hoc-news.de
Senseonics Q2 results: $14.5M revenue, raised guidance - scanx.trade
SENS - Finviz
Why is Beta Bionics stock rallying today? - Investing.com India
A year-long glucose sensor is planned to work with an automated insulin pump. - stocktitan.net
Senseonics (NYSE:SENS) Enters A High-Stakes Liquidity Test - Kalkine Media
Senseonics To Participate in Upcoming Institutional Investor Conferences - manilatimes.net
A glucose monitor can measure levels for up to 365 days. Senseonics plans two conferences. - Stock Titan
What macro factors could move Senseonics Holdings (AMEX:SENS) shares this week? - Kalkine Media
What is moving attention toward Senseonics Holdings (NYSE:SENS) shares before today’s session? - Kalkine Media
Senseonics Holdings stock stabilizes while investors wait for fresh results - ad-hoc-news.de
Senseonics Holdings (SENS) Advances 3.36% to $9.54, Approaching Key ResistanceChange of Character - vinanet.vn
Senseonics Holdings Inc. (SENS) Peer Comparison – Compare with Others - Value Research
Senseonics (SENS) Quarterly Results: Reported EPS Tops Expectations in the Latest Session; Share Response: The Market Price Moves 1.49% Higher at the ClosePost-Earnings Drift - dars.gov.et
Douglas Roeder Bought 9.5% More Shares In Senseonics Holdings - simplywall.st
Senseonics (SENS) Results at a Glance: The Bottom-Line Figure Outpaces Its Comparison on the Day; Market Move: The Stock Gains 10.09%Revenue Beat Analysis - careplusvn.com
Senseonics Holdings Inc (SENS) Director Douglas Roeder Buys 13,9 - GuruFocus
Senseonics Director Douglas A. Roeder Acquires Nearly 14,000 Shares in Open Market Transaction - Kalkine Media
Senseonics director Douglas Roeder buys $125,300 in shares By Investing.com - Investing.com Nigeria
Senseonics director Douglas Roeder buys $125,300 in shares - Investing.com
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Director Douglas Roeder Purchases 13,953 Shares - MarketBeat
Senseonics Holdings (SENS) director boosts stake to 171,191 shares - Stock Titan
FRESH BREAKOUT | SENS STOCK ANALYSIS | SENSEONICS HOLDINGS STOCK - YouTube
Senseonics Holdings Inc (STU:6L60) Stock Price, Trades & News - GuruFocus
Senseonics(SENS) Stock Options Chain | Quotes & News - Moomoo
Senseonics Holdings (SENS) Climbs 1.03% to $7.81 as CGM Sector Draws Fresh AttentionRounding Bottom - vinanet.vn
Sessa Capital (SENS) discloses 9.9% Senseonics stake with 8M warrant shares - Stock Titan
Senseonics Holdings, Inc.Common Stock (Nasdaq:SENS) Stock Quote - The Chronicle-Journal
Inside Senseonics’ commercial overhaul and what’s next - MedTech Dive
SENS Q2 2026 Earnings: Slight EPS Upside Fails to Offset 2.52% Stock DeclinePeak Earnings Alert - careplusvn.com
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches? - TradingView
DXCM Stock Up Nearly 35% YTD: Will the Uptrend Continue in the Rest of 2026? - TradingView
Senseonics Holdings (FRA:6L60) Total Deposits - GuruFocus
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Senseonics Holdings Inc Stock (SENS) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):